Patient satisfaction and adverse response from prevention with 240mg galcanezumab of episodic cluster headache

被引：0
|
作者：
Mo, H. [1 ]
Kim, B. K. [2 ]
Moon, H. S. [3 ]
Cho, S. J. [1 ]
机构：
[1] Hallym Univ, Dongtan Sacred Heart Hosp, Neurol, Hwaseong Si, Gyeonggi Do, South Korea
[2] Eulji Univ, Nowon Eulji Med Ctr, Neurol, Seoul, South Korea
[3] Kangbuk Samsung Hosp, Neurol, Seoul, South Korea
来源：
CEPHALALGIA | 2021年 / 41卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0157
引用
收藏
页码：100 / 101
页数：2
相关论文
共 30 条
  • [1] Patient satisfaction and adverse response from prevention with 240mg galcanezumab of episodic cluster headache
    Mo, H.
    Kim, B. K.
    Moon, H. S.
    Cho, S. J.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 67 - 67
  • [2] Trial of Galcanezumab in Prevention of Episodic Cluster Headache
    Goadsby, Peter J.
    Dodick, David W.
    Leone, Massimo
    Bardos, Jennifer N.
    Oakes, Tina M.
    Millen, Brian A.
    Zhou, Chunmei
    Dowsett, Sherie A.
    Aurora, Sheena K.
    Ahn, Andrew H.
    Yang, Jyun-Yan
    Conley, Robert R.
    Martinez, James M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (02): : 132 - 141
  • [3] Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache
    Lesley J. Scott
    Drugs, 2020, 80 : 893 - 904
  • [4] Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache
    Scott, Lesley J.
    DRUGS, 2020, 80 (09) : 893 - 904
  • [5] Correction to: Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache
    Lesley J. Scott
    Drugs, 2020, 80 : 1379 - 1379
  • [6] Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache
    Mo, Heejung
    Kim, Byung-Kun
    Moon, Heui-Soo
    Cho, Soo-Jin
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [7] Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache
    Heejung Mo
    Byung-Kun Kim
    Heui-Soo Moon
    Soo-Jin Cho
    The Journal of Headache and Pain, 2022, 23
  • [8] Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache (vol 80, pg 893, 2020)
    Scott, Lesley J.
    DRUGS, 2020, 80 (13) : 1379 - 1379
  • [9] Efficacy Results from an Open-Label Safety Study of Galcanezumab in Patients with Episodic or Chronic Cluster Headache
    Gaul, C.
    Riesenberg, R.
    Stroud, C.
    Dong, Y.
    Oakes, T. Myers
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 234 - 235
  • [10] Efficacy Results from an Open-Label Safety Study of Galcanezumab in Patients with Episodic or Chronic Cluster Headache
    Gaul, C.
    Riesenberg, R.
    Stroud, C.
    Dong, Y.
    Oakes, T. Myers
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 2):
123